Verana Health

Verana Health is a San Francisco-based real-world data (RWD) and evidence (RWE) company, founded in 2018, that has established itself as a key player in the digital health analytics space. Its core asset is exclusive access to massive, de-identified clinical datasets from medical society partnerships, notably the American Academy of Ophthalmology's IRIS Registry and the American Urological Association's Quality Registry. By applying its proprietary AI/ML technology platform to these datasets, Verana provides data-as-a-service (DaaS), software-as-a-service (SaaS), and analytical insights to life sciences companies, researchers, and physicians, aiming to streamline drug development and enhance commercial strategies. The company's recent merger with oncology RWD firm COTA significantly expanded its scale and therapeutic reach.

Proprietary AI and machine learning platform that ingests, curates, and analyzes large-scale, longitudinal real-world clinical data from exclusive medical society partnerships. It uses NLP and computer vision to extract insights from unstructured notes and images, and tokenization to create de-identified patient journeys.

Verana Health competes in a crowded real-world evidence market against large players like IQVIA, Flatiron Health (owned by Roche), and TriNetX, as well as EHR vendors (e.g., Epic, Veradigm) and other specialty-focused RWD firms. Its key competitive advantages are exclusive, society-sourced data in ophthalmology and urology, direct physician-generated data (not just claims), and integrated imaging data, which many competitors lack.